- Home
- LMFA vs ADIL Comparison
LMFA vs ADIL Comparison
Compare LMFA & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LMFA | ADIL |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 6.4M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LMFA | ADIL |
|---|---|---|
| Price | $0.42 | $0.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $1.50 |
| AVG Volume (30 Days) | ★ 496.2K | 337.7K |
| Earning Date | 11-14-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,567,508.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.58 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $0.21 |
| 52 Week High | $5.14 | $1.30 |
Technical Indicators
Market Signals| Indicator | LMFA | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 33.26 | 41.60 |
| Support Level | $0.40 | $0.21 |
| Resistance Level | $0.46 | $0.24 |
| Average True Range (ATR) | 0.05 | 0.02 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 19.44 | 40.74 |
Price Performance
Historical ComparisonAbout LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.